- DailyMed: CombiPatch prescribing information and patient labeling - DailyMed: Climara Pro prescribing information and patient labeling - FDA Orange Book data files - FDA Orange Book June 2026 cumulative supplement - FDA: Menopausal Hormone Therapies with Updated Prescribing Information

Does Insurance Cover CombiPatch? What 11 Plan Documents Say in 2026

Last updated: August 3, 2026 · U.S. insurance coverage research. Editorial information, not medical advice, and not reviewed by a clinician. See our medical review policy. Full disclosure.

If coverage is part of a bigger HRT decision

Coverage is one variable. Your route, symptoms, risk history, state, and whether online care is the right starting point matter too.

Find My HRT Path

Does insurance cover CombiPatch? Some plans do. All 11 current 2026 documents in our evidence sample place it on a formulary or preferred-alternative side, but that still does not guarantee your exact benefit. Its position ranges from preferred to Tier 3, with quantity limits, step therapy, restricted pharmacies, or an HRM flag in some documents.

By The HRT Index editorial team · Last verified: August 2026

Editorial research — not medical advice, and not medically reviewed by a clinician.

The fastest useful answer is to separate four benefit types. Commercial plans can list CombiPatch without guaranteeing a member’s exact coverage; Medicare and Medicaid rules vary by plan; and cash payment is not insurance. The table below shows what the current evidence supports before you open your own benefit documents.

Your coverage type	The short answer
Commercial or employer plan	Some plans cover CombiPatch. In the documents we checked, it ranged from a named preferred alternative to Tier 3 with a quantity limit. The exact employer benefit still controls.
Medicare Part D or Medicare Advantage	Some specific formularies list it. Two current Medicare examples in this page place it at Tier 3; one also carries an HRM flag for people 65 and older.
Medicaid	It varies by state and managed-care plan. One current Colorado Medicaid-plan example lists it at Tier 2 with a $0 copay, but step therapy, a restricted-pharmacy rule, and an eight-patch quantity limit still apply.
No insurance or paying cash	This is not coverage. The official manufacturer offer may let eligible cash-paying patients pay as little as $25, with a variable maximum benefit. Publisher coupon estimates checked August 3, 2026 were roughly $247 to $269 for eight patches.

Best for you if: you have a CombiPatch prescription and got a price you did not expect · the pharmacy returned a rejection · your plan lists PA, ST, QL, LA, HRM, or Tier 3 · your plan dropped Climara Pro and named CombiPatch instead · you want the right question to ask before paying.

Not the right page if: you need a clinician to decide whether CombiPatch is appropriate for you · you had a hysterectomy, because the current patient labeling says not to use CombiPatch after the uterus has been removed · you are still deciding whether hormone therapy is right for you at all.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

Does insurance cover CombiPatch in 2026?

Yes, some plans cover CombiPatch, but a drug-list entry is not a promise that your exact benefit pays for it. One UnitedHealthcare commercial document lists CombiPatch at Tier 3 with a quantity limit while warning that closed two-tier benefits generally may not cover Tier 3 drugs. Your member benefit and live pharmacy claim decide the answer.

Here is what we cannot do, and why it matters

We cannot tell you your copay from your insurance card.

That sounds like a cop-out. It is not. It is the single most useful thing on this page.

UnitedHealthcare does not have one drug list. Neither do Aetna, CVS Caremark, Express Scripts, Kaiser, or most other large benefit organizations. Your employer may select a particular formulary. A plan sponsor may add exclusions. A pharmacy benefit manager may process the prescription even though another company’s name is printed on your medical-insurance card.

Then the benefit design changes what a formulary entry means. The UnitedHealthcare 2026 commercial Prescription Drug List lists CombiPatch at Tier 3 with a quantity limit, but the same document says the list does not define member coverage and that medications in Tier 3 are generally not covered under certain closed two-tier benefits.

Same drug. Same document. A listing—and a warning not to treat the listing as your answer.

So instead of guessing from an insurer logo, we opened the current documents, recorded exactly what each one says, and separated the document-level finding from the member-level answer only your plan can give.

The right online HRT provider is not the same for every woman

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

What do 11 current 2026 plan documents say about CombiPatch?

Across 11 current documents—not 11 independent insurers—CombiPatch appears on a formulary, preferred list, or preferred-alternative side in every document. That is stronger evidence than “some plans may cover it,” but it is not a national coverage rate. Several documents explicitly say the individual benefit, employer adoption, Evidence of Coverage, or member materials still control.

The HRT Index 2026 CombiPatch Formulary Ledger

This ledger records document-level evidence rather than pretending each row is a member guarantee. Four rows come from Express Scripts document families, two from Aetna/CVS Caremark templates, and the remaining rows from named commercial, public-employee, Medicare, or Medicaid documents. The final column states the exact limit of each finding.

#	Current document	Market and date	What the document says about CombiPatch	Rules or limits	What that does—and does not—establish
1	Express Scripts National Preferred Formulary	Commercial template; effective January 1–December 31, 2026; July 2026 version	Listed on the abbreviated covered-drug list	No CombiPatch-specific code shown in the abbreviated list	It is on this template’s covered-drug list. Express Scripts says the list is not all-inclusive, does not guarantee coverage, and is not adopted by every prescription plan.
2	Express Scripts National Preferred Formulary Exclusions	Commercial template; effective 2026; revised July 1, 2026	Named preferred alternative when Climara Pro is excluded	Coverage review may be requested for the excluded product	It establishes the template’s preferred direction, not the member’s tier, copay, or employer-specific adoption.
3	Express Scripts National Preferred Flex Formulary Exclusions	Commercial template; effective 2026; revised July 1, 2026	Named preferred alternative when Climara Pro is excluded	Plan-specific coverage still controls	It confirms the same combination-patch preference in the Flex template, not a second independent insurer decision.
4	Express Scripts Basic Formulary	Commercial template; effective January 1–December 31, 2026; July 2026 version	Listed on the abbreviated covered-drug list	No CombiPatch-specific code shown in the abbreviated list	It is listed, but the document says listing does not guarantee coverage under every prescription plan.
5	Aetna/CVS Caremark Standard Control Plan exclusions	Commercial template; July 2026	Preferred option when Climara Pro is excluded	Exact tier and copay are not stated	It establishes the Standard Control template’s payment preference. Aetna says preferred options do not necessarily represent clinical equivalency.
6	Aetna/CVS Caremark Advanced Control Plan exclusions	Commercial template; July 2026	Preferred option when Climara Pro is excluded	Exact tier and copay are not stated	It establishes the Advanced Control template’s payment preference, not universal Aetna coverage.
7	UnitedHealthcare Commercial Prescription Drug List	Commercial; effective January 1, 2026	Tier 3	QL	The PDL lists it at the highest-cost tier in this document. UHC also says the PDL does not define member coverage and that certain closed two-tier benefits generally do not cover Tier 3 drugs.
8	UnitedHealthcare Group Medicare Advantage Formulary 00026005	Group Medicare Advantage; 2026 formulary; last updated October 1, 2025	Brand, Tier 3	HRM; no PA code appears beside the entry	It is listed as a non-preferred brand in this exact formulary. The HRM flag is not itself a PA code. Member cost still depends on the plan and coverage stage.
9	Kaiser Permanente Washington Medicare large-employer group formulary	Medicare large-employer group; effective August 1, 2026	Tier 3	No CombiPatch-specific PA, ST, or QL code shown	It is listed in this named formulary. Kaiser says drug coverage is based on each member’s contracted benefit and coverage agreement.
10	Denver Health Elevate Medicaid Choice and CHP+ formulary	Colorado Medicaid and CHP+ plan; Q1 2026	Tier 2; $0 formulary copay	LA + ST + QL; eight patches per 28 days	It is listed with a $0 plan copay, but generally must be filled at a Denver Health Pharmacy unless authorization permits another pharmacy, and step therapy applies.
11	New York State Empire Plan Advanced Flexible Formulary	Public-employee plan administered by CVS Caremark; January 2026	Listed in the preferred drug list with Climara Pro	Preferred brands are generally Level 2; plan materials set the amount	It shows that this plan kept both combination patches on its preferred list instead of excluding one for the other.

What this sample proves: CombiPatch is present across current commercial, public-employee, Medicare, and Medicaid documents. It can be a named preferred alternative, a preferred-list drug, a Tier 2 drug, or a Tier 3 drug. It also appears with QL, ST, LA, and HRM codes in different documents.

What this sample does not prove: it is not a national coverage percentage. It does not tell you what your employer adopted, whether your benefit is open or closed, which strength is covered, whether a deductible applies, or what the pharmacy will charge today.

The finding that matters most

Look at the same two patches across four benefit designs:

Express Scripts and Aetna/CVS Caremark exclusion templates remove Climara Pro and name CombiPatch as the preferred alternative.
The Empire Plan lists both CombiPatch and Climara Pro on its preferred list.
UnitedHealthcare’s commercial PDL places both at Tier 3 with a quantity limit.
Denver Health lists both at Tier 2, but applies different quantity limits and gives CombiPatch a step-therapy rule.

Four answers. Same year. Same drug category.

That is not a contradiction. That is the actual shape of prescription coverage—and why “Does my insurer cover it?” is the wrong first question.

The useful question is:

What does my exact 2026 benefit do with CombiPatch, and what did the live claim return?

How do I check whether my own plan covers CombiPatch?

The reliable method is to identify your exact benefit, search its current formulary for both CombiPatch and estradiol/norethindrone acetate, record every tier and restriction code, and then confirm the live pharmacy claim for eight patches over 28 days. An insurer’s name or a general internet drug list cannot establish your member price.

Ten minutes. Five steps. Do them in order.

Step 1 — Find your exact plan, not just your insurer

Write down:

The full plan name.
Your employer or group name, if applicable.
The formulary or prescription-drug-list name.
Your Medicare formulary ID, if applicable.
The benefit year.
The company that processes pharmacy claims.
Whether the benefit is fully insured or self-funded if you are preparing an appeal.

The phone number on the pharmacy-benefit card or the prescription section of your member portal is usually more useful than the medical-benefit number.

Step 2 — Search two names, not one

Search the formulary for:

CombiPatch
estradiol/norethindrone acetate
transdermal system
twice-weekly patch

The current FDA label lists two CombiPatch strengths:

0.05 mg estradiol/0.14 mg norethindrone acetate per day
0.05 mg estradiol/0.25 mg norethindrone acetate per day

Each carton contains eight systems. Check whether the formulary separates the strengths or dosage forms rather than assuming a single result covers both.

Step 3 — Copy the entry exactly

Record:

Listed, excluded, not listed, or unknown.
Tier.
PA, ST, QL, LA, HRM, or another code.
Quantity and days’ supply.
Fixed copay or percentage coinsurance.
Preferred or required pharmacy.
Mail-order or 90-day rules.
Exception or coverage-review instructions.

Do not translate a code from memory. Use the key printed in that exact document.

Step 4 — Make the pharmacy run the claim

If the prescription is already at the pharmacy, ask:

Did the claim pay, or did it reject?
What is the exact rejection code or message?
Is the displayed amount a copay, coinsurance, or deductible charge?
Was the correct strength and package billed?
Would a preferred in-network pharmacy change the amount?
What is the next covered fill date if the message says refill too soon?

If there is no prescription yet, ask Member Services for a benefit estimate. A pharmacy cannot run a live claim for a prescription it does not have.

Step 5 — Compare savings only after you have the insurance result

Insurance, a pharmacy discount card, and the manufacturer offer are different payment routes.

A cash or discount-card purchase may bypass the insurance claim and generally may not count toward your insurance deductible or out-of-pocket total. Get the benefit result first. Then decide which route is actually cheaper for this fill and for the year.

The five-minute call script

“I’m checking coverage for CombiPatch—estradiol/norethindrone acetate transdermal system, eight patches for 28 days. Is it on my exact 2026 formulary? What tier is it? Does it have prior authorization, step therapy, a quantity limit, a restricted-pharmacy rule, or an HRM flag? What would I pay at a preferred in-network pharmacy, and is that amount a copay, coinsurance, or deductible charge?”

Your copyable CombiPatch coverage worksheet

This worksheet keeps the plan, pharmacy, and prescriber from answering three different questions. Fill it out before an appeal or exception request. It asks for no diagnosis, member ID, date of birth, or medical record. The most important line is whether the claim paid or rejected, because those two outcomes require different fixes.

Field	Your answer
Exact plan and benefit year
Formulary or PDL name
Pharmacy-benefit manager
CombiPatch status	Listed / excluded / not listed / unknown
Tier
Codes	PA / ST / QL / LA / HRM / other
Quantity and days’ supply	8 patches / 28 days, or plan result
Live claim	Paid / rejected / not yet submitted
Price type	Copay / coinsurance / deductible / unknown
Exact rejection message
Required pharmacy
Who must act next	Plan / pharmacy / prescriber / patient
Deadline or next fill date

Keep a screenshot or PDF of the exact formulary page. Save the date, name, and reference number from every call.

What do Tier 3, PA, ST, QL, LA, and HRM mean?

These codes describe cost position or conditions attached to payment, not whether CombiPatch is medically appropriate. Definitions vary. In the 11 documents reviewed here, CombiPatch carried QL, ST, LA, and HRM flags in different entries, while no entry displayed an explicit PA code. Your exact benefit can still use different rules.

Code	What it means in plain English	What to ask
Tier 2	A plan-defined tier. It may be preferred or non-preferred depending on the document; Denver Health defines Tier 2 as non-preferred.	“What is my 28-day copay or coinsurance under this exact benefit?”
Tier 3	A higher-cost or non-preferred tier in many plans. It is not automatically covered under every benefit design.	“Is Tier 3 covered under my benefit, and is this a copay, coinsurance, or deductible amount?”
PA	Prior authorization. The plan requires information or approval before paying.	“What are the exact criteria, and what must my prescriber submit?”
ST	Step therapy. The plan requires a listed alternative first unless the history or an exception satisfies the rule.	“Which products count, and does my prior treatment already satisfy the step?”
QL	Quantity limit. The plan restricts the covered amount or timing.	“Is eight patches per 28 days within my limit?”
LA	Limited access under the plan’s definition. In the Denver example, it means Denver Health Pharmacy unless a pharmacy authorization is approved.	“Which pharmacy must fill it, and can another pharmacy be authorized?”
HRM	High-risk-medication flag in the cited Medicare document for people 65 and older.	“Does this entry carry any separate coverage restriction, or is the flag asking for a prescriber discussion?”
Nonformulary	The drug is not on the ordinary covered-drug list.	“Can my prescriber request a formulary exception?”

HRM is not the same as prior authorization

The UnitedHealthcare Group Medicare Advantage entry lists CombiPatch as Tier 3 with HRM. It does not display a PA code beside CombiPatch.

The document defines HRM as a high-risk-medication flag for people 65 and older and directs the member to discuss the medication with the prescriber. That does not make the flag meaningless. It means the document is signaling a medication-safety conversation, not labeling the entry “PA.”

Read the code. Then read that plan’s key. Do not spend two weeks building paperwork for a restriction the entry does not show.

Is there a generic CombiPatch?

No FDA-approved generic CombiPatch transdermal system appears in the current FDA Orange Book data reviewed for this page on August 3, 2026. The FDA data lists CombiPatch under NDA 020870. Oral estradiol/norethindrone acetate tablets and a separately prescribed estradiol patch plus a progestogen are different products or regimens, not generic CombiPatch.

Now we are at the thing almost every cost guide tells you to do:

Ask the pharmacist for the generic.

For CombiPatch, there is no FDA-approved generic patch to substitute.

The FDA’s Orange Book data files distinguish an NDA innovator product from an ANDA generic product. The current CombiPatch transdermal entry we reviewed is the Noven product under NDA 020870, without a listed ANDA generic counterpart.

Three things people may mean when they say “the generic”

The phrase often hides three different decisions: a pharmacist substitution, a prescriber-directed route change, or a custom compounded product. Only the first would be a generic substitution for CombiPatch, and the current FDA data does not show one. The other options require a separate clinical and coverage decision.

What someone suggests	Is it generic CombiPatch?	What changes
An FDA-approved oral estradiol/norethindrone acetate tablet	No	Different dosage form and route. A prescriber—not a pharmacist acting as if it were the same prescription—decides whether to change it.
A generic estradiol patch plus a separately prescribed progestogen	No	Two prescriptions, separate dosing, separate tiers, and separate clinical considerations.
Climara Pro	No	Different progestin, weekly wear schedule, labeled indications, storage instructions, and formulary position.
A compounded estradiol/norethindrone preparation	No	A compounded preparation is not FDA-approved and is not an FDA-approved generic substitute for CombiPatch. Coverage must be checked separately.

The absence of a generic is a real budget problem. It removes the easiest pharmacy-level substitution and makes the plan’s brand tier, manufacturer offer, exception process, and covered alternatives matter more.

It does not prove that plans prefer CombiPatch because no generic exists. The documents show the preference; they do not publish that causal explanation.

Why is CombiPatch expensive even when insurance covers it?

A covered prescription can still produce a high price because of an unmet deductible, a higher brand tier, percentage coinsurance, a non-preferred pharmacy, or Medicare coverage stage. The first question is not “Why was I denied?” It is “Did the claim pay or reject?” Those outcomes have different fixes.

This is the most important distinction on the page:

Denied and expensive are two different problems.

Get this wrong and you can spend weeks appealing a claim the plan already accepted.

A rejection means the plan or claim system blocked payment; a high accepted amount means the benefit calculated a member share. The first path needs a rejection-specific fix. The second needs cost math, pharmacy-network verification, or a tiering request. Ask the pharmacy which result occurred before choosing a remedy.

What happened	What it means	What to do first
The claim rejected	A coverage rule, exclusion, missing authorization, pharmacy restriction, refill-timing issue, or billing mismatch blocked payment.	Get the exact rejection code and match it to the correct fix.
The claim paid but the amount is high	The drug may be covered, while the deductible, tier, coinsurance, or network price creates the amount.	Confirm the benefit calculation, preferred-pharmacy price, and whether a tiering exception is available.

Ask the pharmacist:

“Did this claim pay, or did it reject?”

Five reasons a covered prescription can still cost a lot

Your deductible is not met. You may owe the plan-negotiated amount before the ordinary copay or coinsurance applies.
CombiPatch is on a higher brand tier. The UHC commercial and two Medicare documents in our ledger place it at Tier 3.
Your benefit uses coinsurance. A percentage of the negotiated price behaves differently from a fixed copay.
The pharmacy is not preferred. The same covered drug can produce a different member amount at another in-network pharmacy.
Your Medicare coverage stage changed. Deductible, initial coverage, and catastrophic coverage apply different member-cost rules.

What current cash-price publishers show

We checked the same package—eight 0.05/0.14 mg-per-day patches—across three price publishers on August 3, 2026. These are changing coupon or benchmark figures, not pharmacy quotes and not insurance prices. SingleCare’s lowest figure includes a one-time $3 signup bonus. Your location, pharmacy, strength, and coupon processing can change the amount.

Publisher	Undiscounted or retail benchmark	Coupon or cash estimate checked August 3, 2026
SingleCare	About $375.92	$246.82 with one-time $3 signup bonus; $249.82 without that bonus
GoodRx	Average retail about $344.99	Average coupon about $268.69
Drugs.com	Not stated in the same format	From $267.81 for eight patches; cash-paying estimate

The retail anchors differ by about $31 between the two publishers that display them. The coupon figures cluster more tightly, but they still are not guarantees.

Anchor on the dollar you will actually pay at the named pharmacy—not the advertised percentage saved.

Eight patches is 28 days, not one calendar month

The current label instructs a new system every three to four days, twice weekly, and each carton contains eight systems. On that schedule:

One carton covers 28 days.
Thirteen cartons cover 364 days.
Twelve cartons cover 336 days—28 days short of a 364-day treatment year.

That matters when you compare an annual benefit, a 12-fill manufacturer limit, or a budget written as “monthly.”

Does Medicare cover CombiPatch?

Some Medicare Part D and Medicare Advantage formularies list CombiPatch, but Medicare has no single national formulary. In this evidence sample, one UnitedHealthcare Group Medicare Advantage formulary lists it as a Tier 3 brand with an HRM flag, and a Kaiser Washington large-employer group formulary lists it at Tier 3. The exact plan controls.

Two current Medicare examples

UnitedHealthcare Group Medicare Advantage Formulary 00026005: CombiPatch is listed as a brand, Tier 3, with HRM. No PA code appears beside the entry.
Kaiser Permanente Washington Medicare large-employer group three-tier formulary: CombiPatch is listed at Tier 3, effective August 1, 2026. Kaiser says each member’s contracted benefit and coverage agreement control.

Neither example predicts every Part D or Medicare Advantage plan.

What Medicare drug coverage can cost in 2026

Medicare’s 2026 Part D rules set national ceilings and stages, but the exact plan can have a lower deductible, different covered-drug prices, and different network rules. After any deductible, Medicare says members generally pay 25% coinsurance for covered Part D drugs until covered out-of-pocket spending reaches the annual cap.

2026 Part D item	Current federal rule
Maximum annual deductible	$615; some plans have no deductible
Initial coverage member share	Generally 25% coinsurance after the deductible for covered generic and brand-name Part D drugs
Annual out-of-pocket cap for covered Part D drugs	$2,100
After reaching the cap	$0 out of pocket for covered Part D drugs for the rest of the calendar year

A high covered cost can move a member toward the $2,100 cap faster, but the timing depends on every covered fill and what Medicare counts toward the total. A coupon or cash transaction outside the Part D claim may not count.

The hardest budget path

Here is the damaging admission:

A Medicare member whose plan excludes CombiPatch has fewer easy price protections than a commercially insured patient.

The official CombiPatch offer is not valid for Medicare, Medicare Advantage, or Part D.
Current FDA data does not show an approved generic CombiPatch patch.
We found no separate official Noven patient-assistance program in the manufacturer materials reviewed for this page.

That does not leave “nothing.” It leaves a less pleasant set of choices:

Request a formulary exception.
Request a tiering exception if the drug is covered but non-preferred.
Ask the prescriber whether a covered FDA-approved alternative fits the treatment goal.
Compare an outside cash discount, knowing it generally will not count toward Part D out-of-pocket spending.
Check eligibility for Extra Help or a state pharmaceutical assistance program.
Use the Medicare Prescription Payment Plan to spread eligible Part D costs across the year.

If a guaranteed low price is the first priority, CombiPatch may be the wrong budget fit. We would rather say that before six weeks of phone calls.

If the Medicare plan does not list it

CMS recognizes three distinct requests:

Formulary exception: request coverage of a Part D drug not on the plan’s formulary.
Tiering exception: request lower preferred-tier cost sharing for a covered non-preferred drug.
Request to waive utilization management: ask the plan to waive PA, ST, or QL when medically supported.

CMS says the prescriber must submit a supporting statement for an exception.

The Medicare clock

The deadlines below come from the current CMS Part D coverage-determination and appeals process. A plan notice controls the individual case. For an exception, the decision clock depends on the plan receiving the prescriber’s supporting statement—not merely the patient making a phone call.

Step	Current federal timeframe
Standard coverage determination	72 hours
Expedited coverage determination	24 hours
File a Level 1 redetermination	Generally within 65 days
Standard Level 1 benefits decision	7 days
Expedited Level 1 decision	72 hours
File the next appeal level	Generally within 60 days of the prior decision

Confirm that the prescriber’s statement was sent. Get the submission date and reference number.

The Medicare Prescription Payment Plan

The Medicare Prescription Payment Plan does not reduce the total drug cost. It changes timing: instead of paying the pharmacy at pickup, the member receives monthly bills from the health or drug plan.

That can solve a cash-flow problem. It does not solve a coverage exclusion or lower the annual total.

Does Medicaid cover CombiPatch?

Medicaid coverage is state- and plan-specific, so there is no national answer. The current Denver Health Elevate Medicaid Choice and CHP+ example lists both CombiPatch strengths at Tier 2 with a $0 copay across formulary tiers, but also applies limited access, step therapy, and a quantity limit of eight patches per 28 days.

That Denver entry is the clearest example on this page of why “$0 copay” and “easy to get” are not the same sentence.

What the document says:

Tier 2, which Denver defines as non-preferred.
$0 copay across all formulary tiers.
ST: failure of one listed oral estradiol/norethindrone product or an estradiol transdermal patch.
QL: eight patches per 28 days.
LA: generally fill at a Denver Health Pharmacy unless a prior authorization request permits another pharmacy.

So the member price can be zero, and the prescription can still stop at the pharmacy.

Six questions to ask a Medicaid plan

Is CombiPatch on the state preferred drug list or my managed-care plan’s formulary?
Are both strengths listed?
What treatment history satisfies the step?
Does my existing record already satisfy it?
Which pharmacy must fill it?
What is the plan’s appeal or fair-hearing process?

The Denver example tells you what one Colorado plan does. It does not predict another Colorado plan, another state, or a future quarter.

Can I use the CombiPatch savings card with insurance?

Eligible commercially insured and cash-paying U.S. patients may pay as little as $25 per prescription through the January 2026 official CombiPatch offer. The maximum benefit varies, the offer is limited to one use per month and up to 12 prescriptions per year, and it is not valid for Medicare, Medicaid, or other government-funded coverage.

The official terms

The manufacturer’s phrase is “may pay as little as $25.” It is not “pay only $25.” The variable maximum benefit means the program may not absorb the entire balance on a high copay or cash transaction. Eligibility, pharmacy participation, coordination of benefits, and the terms in effect on the fill date still control.

Term	Current January 2026 offer
Advertised patient amount	May pay as little as $25 per prescription
Maximum benefit	Variable
Commercial insurance	Potentially eligible
Cash-paying patient	Potentially eligible
Medicare, Medicare Advantage, Part D	Not eligible
Medicaid or other federal/state-funded coverage	Not eligible
Annual limit	Up to 12 prescriptions per year
Frequency limit	One use per month
Other discounts	Cannot be combined with another free trial, discount card, prescription savings card, or offer
Program status	This is not insurance
Support number	1-833-483-2178

For an eligible third-party-payer patient, the pharmacy first submits the claim to the primary payer, then submits the remaining balance to the card as a secondary payer. For an eligible cash-paying patient, the pharmacy processes the card as the primary payer.

The honest arithmetic

We are not going to let a “$25” headline do work it cannot do.

The benefit maximum is variable.
Twelve uses do not automatically cover thirteen 28-day cartons in a 364-day treatment year.
A fill processed outside insurance may not count toward the insurance deductible or out-of-pocket total.
The amount at the counter must be confirmed before you build a budget around it.

Check the current official CombiPatch savings-offer terms →

This is the manufacturer’s site, not an affiliate link.

Why was my CombiPatch claim rejected, and what do I do next?

The exact rejection message determines the fix. A claim can fail because CombiPatch is excluded, requires a plan review or step therapy, exceeds a quantity limit, was sent to a restricted pharmacy, is being refilled too early, or was billed with the wrong strength or package. Do not file a generic appeal before identifying the problem.

Find the message. Take the matching action.

The table below is a routing tool, not a substitute for the exact denial notice. Each message points to a different owner and document: the plan for benefit exclusions, the prescriber for clinical criteria, the pharmacy for billing or network errors, and the patient for deadline tracking and recordkeeping.

What the pharmacy or letter says	What may be happening	Your first move
Not covered / product not covered	Formulary or benefit exclusion	Ask for the exact member formulary, covered alternatives, and formulary-exception process.
Prior authorization required	PA	Get the written criteria and confirm the prescriber received the request. Record the submission date.
Step therapy required	ST	Identify the exact required products. If already tried, ask whether the documented history satisfies the step or supports an exception.
Quantity exceeded	QL or days’-supply mismatch	Confirm the directions, strength, and whether eight patches per 28 days is within the plan limit.
Pharmacy not authorized	LA or network restriction	Transfer to the required pharmacy or ask whether another pharmacy can be authorized.
Refill too soon	Timing	Ask for the next covered fill date and whether travel or lost-medication rules apply.
The claim paid but the price is high	Deductible, tier, coinsurance, or pharmacy network	Do not start with a denial appeal. Confirm the price calculation and ask whether a tiering exception or preferred pharmacy helps.
Invalid or mismatched product code	Wrong strength, package, or billing code	Have the pharmacy verify the exact CombiPatch product submitted.
Benefit exclusion	Contract-level exclusion	Request the exclusion in writing and ask which exception, grievance, or appeal route applies.

Do not pay cash before you know the reason. A cash purchase can bypass the insurance claim, may not count toward insurance spending, and can erase the clearest evidence of what the plan actually did.

There are situations where a patient and clinician decide not to delay treatment. That is a clinical decision. The coverage rule still should be documented.

Commercial and Marketplace appeal timing

For many non-grandfathered commercial and Marketplace plans, HealthCare.gov gives a 180-day filing window for an internal appeal. It says the plan generally must complete a pre-service appeal within 30 days and a post-service appeal within 60 days. External review is due within 45 days, or 72 hours when expedited.

Appeal point	Federal baseline described by HealthCare.gov
File an internal appeal	Within 180 days of receiving the denial notice
Plan completes a pre-service internal appeal	Within 30 days
Plan completes a post-service internal appeal	Within 60 days
Standard external review	No later than 45 days after the request is received
Expedited external review	No later than 72 hours, or sooner when medical urgency requires

Self-funded employer plans, grandfathered plans, state processes, and pharmacy-benefit contracts can follow different rules. The deadline printed on the denial notice is the one to calendar.

What belongs in a coverage-exception request

A strong request matches the plan’s actual criteria. Depending on the truthful medical record, the prescriber may document:

The exact drug, strength, route, and labeled regimen requested.
Prior covered alternatives tried and the results.
Why a preferred drug would not be as effective or would cause adverse effects for this patient.
Why the transdermal route was selected when the plan suggests an oral product.
Why the requested quantity is medically necessary.
The exact member formulary being applied.
The FDA label or relevant clinical documentation requested by the plan.

Do not attach another employer’s formulary and claim it controls your plan. Use the ledger to know what is possible, then make the plan identify the exact document it is applying.

Use our menopause HRT prior-authorization and appeal guide to build the full request →

CombiPatch vs. Climara Pro: which one might my plan prefer?

CombiPatch and Climara Pro are the two FDA-approved combination patches compared here. Neither has an FDA-approved generic in the current Orange Book data reviewed. Express Scripts and Aetna/CVS Caremark templates in this ledger exclude Climara Pro and name CombiPatch, while the Empire Plan lists both and UnitedHealthcare’s commercial PDL places both at Tier 3 with QL.

Decision fact	CombiPatch	Climara Pro
Hormones	Estradiol + norethindrone acetate	Estradiol + levonorgestrel
FDA-labeled wear schedule	Twice weekly; every 3–4 days	Once weekly
FDA-listed strengths	Two: 0.05/0.14 and 0.05/0.25 mg per day	One: 0.045/0.015 mg per day
FDA-approved generic in current data	No	No
Menopausal osteoporosis-prevention indication	No	Yes
Labeled storage	Refrigerator, 36°F–46°F	Room temperature, 68°F–77°F
Express Scripts NPF and Flex exclusions	Preferred alternative	Excluded
Aetna Standard and Advanced Control exclusions	Preferred option	Excluded
Empire Plan January 2026 preferred list	Listed	Listed
UHC commercial PDL	Tier 3 + QL	Tier 3 + QL

One labeled indication can change an exception

Climara Pro carries an FDA-approved indication to help reduce the chance of postmenopausal osteoporosis. CombiPatch does not carry that indication.

That does not make Climara Pro “better.” It means the products do not have identical labeling. When osteoporosis prevention is part of the documented treatment goal, the prescriber should use the exact labeled indication and the plan’s criteria rather than treating the two products as interchangeable.

The naming trap

Climara and Climara Pro are not the same product.

Climara is an estrogen-only patch.
Climara Pro contains estrogen and a progestin.

If the prescription, pharmacy label, and expected product do not match, ask the pharmacy and prescriber before using it.

See the full CombiPatch vs. Climara Pro comparison.

Does CombiPatch need refrigeration, and did FDA change its boxed warning?

The current CombiPatch label requires refrigeration at 36°F to 46°F in the sealed pouch and says to let a patch reach room temperature before application. The label, updated February 21, 2024, still carries its full boxed warning. CombiPatch is not on FDA’s current list of six menopause products with updated prescribing information.

The refrigeration question that belongs in a coverage decision

The label does not state a room-temperature storage window. That matters when a benefit steers a member toward mail order or a longer supply.

Before accepting a shipment, ask:

Will it be shipped under refrigerated conditions?
What temperature controls are used in transit?
What should I do if the package arrives warm or damaged?
What is the replacement policy?
Can the local pharmacy order and refrigerate it instead?
Will the plan cover the same days’ supply at retail?

Mail-order pharmacies routinely handle refrigerated medication. This is a verification question, not a reason to reject mail order automatically.

Did FDA remove CombiPatch’s boxed warning?

No.

FDA’s current tracker lists six products with updated prescribing information:

Prometrium
Divigel
Cenestin
Enjuvia
Estring
Bijuva

CombiPatch is not on that list. Its current DailyMed label still begins with the boxed warning covering cardiovascular disorders, breast cancer, endometrial cancer, and probable dementia.

Headlines about menopause-hormone-label changes do not rewrite a product label that has not yet changed.

The sequential regimen can create two coverage answers

The CombiPatch label describes a continuous sequential regimen using an estradiol-only transdermal system for the first 14 days of a 28-day cycle, followed by CombiPatch for the next 14 days.

That is one regimen with two products:

Two prescriptions.
Two formulary searches.
Potentially two tiers, two restrictions, and two member prices.

Do not check CombiPatch alone if the prescribed regimen also includes the estradiol-only phase.

What might insurance ask me to try instead of CombiPatch?

A plan may prefer an oral estradiol/norethindrone acetate product, an estradiol patch plus a separately prescribed progestogen, Climara Pro, or another covered regimen. A formulary preference is a payment decision—not proof of clinical equivalency. Aetna’s own 2026 exclusion documents state that preferred options do not necessarily represent clinical equivalency.

Possible plan-preferred route	What it is	Coverage question
FDA-approved oral estradiol/norethindrone acetate	Oral combination product; not generic CombiPatch	Which exact product and strength are preferred, and what treatment history satisfies the plan?
Estradiol patch plus a separately prescribed progestogen	Two-product regimen; not a CombiPatch substitute at the pharmacy	What tier and restriction applies to each prescription?
Climara Pro	Weekly estradiol/levonorgestrel patch with different labeling and storage	Is it preferred, non-preferred, or excluded under this exact plan?
Formulary exception for CombiPatch	Request to keep the prescribed product	What documentation does the plan require from the prescriber?

Ask the clinician:

“Which covered option fits the treatment goal, route preference, whether I have a uterus, risk history, prior medication response, and the reason CombiPatch was prescribed?”

Do not switch the route, progestogen, or regimen because a coupon page calls something “equivalent.”

For broader cash-price comparisons, see our 2026 HRT cost guide.

Should I verify CombiPatch coverage before paying for an online consult?

Yes—when obtaining brand-name CombiPatch is central to the reason you are booking. A telehealth service can provide legitimate menopause care without accepting your medical insurance, prescribing that exact brand, routing prescriptions to your preferred retail pharmacy, or completing prior-authorization and exception paperwork. A consult gets you clinical access; it does not guarantee a covered prescription.

Ask these six questions before paying:

Can your clinicians prescribe FDA-approved brand-name CombiPatch when medically appropriate?
Is the service available in my state?
Do you accept my exact insurance for the consultation?
Is the medication billed separately through my pharmacy benefit?
Will the clinical team submit PA, step-therapy, or formulary-exception documentation?
What does follow-up or administrative support cost if the plan denies the prescription?

Get the answers in writing when the brand and insurance workflow are dealbreakers.

A service focused on compounded medication is not a substitute for this question. Compounded and FDA-approved medication must remain clearly separated, and a compounded preparation is not generic CombiPatch.

Read our guide to getting a CombiPatch prescription online for the care-access side of the decision.

What did The HRT Index actually verify?

For this page, The HRT Index checked current primary formulary documents, FDA labeling and Orange Book material, the official manufacturer offer, and federal Medicare and commercial-appeal sources. We also captured three changing cash-price publisher figures on one date. We did not access any reader’s private portal, run a member-specific claim, or decide whether the drug is medically appropriate.

Verified for this page

Eleven current 2026 plan, PBM, or formulary documents, with document family and benefit limits disclosed.
CombiPatch’s two labeled strengths, eight-system carton, twice-weekly schedule, and refrigerated storage.
The current CombiPatch boxed warning and FDA’s current six-product updated-label tracker.
The current FDA Orange Book data used for the no-generic finding.
The January 2026 official CombiPatch savings-offer terms.
2026 Medicare deductible, coinsurance stage, out-of-pocket cap, exception categories, and appeal timeframes.
Federal commercial and Marketplace appeal baselines.
Three cash-price publisher figures captured August 3, 2026.

Not verified—and we will not pretend otherwise

Your plan’s coverage, tier, deductible, or copay.
A national CombiPatch coverage percentage.
Any private employer’s unpublished benefit.
Live pharmacy inventory or temperature handling.
Whether a specific clinician will prescribe CombiPatch for your history.
Whether CombiPatch is medically appropriate for you.
A separate official Noven patient-assistance program beyond the savings offer; none appeared in the manufacturer materials reviewed.

The HRT Index Verification Standard

This page was produced under The HRT Index Verification Standard—the documented process used to read every published price, keep FDA-approved and compounded options separate, verify state availability and insurance information, and re-check top providers monthly and the full roster quarterly.

When The HRT Index evaluates providers, it uses exactly five pillars in this order:

clinical legitimacy
care quality
medication fit
price transparency
access

We do not publish invented provider scores.

How this page stays current

Formularies, prices, savings programs, FDA records, and appeal rules change on different schedules. The table below ties each claim type to a specific refresh method. The visible verification date should move only after the underlying source is reopened and the affected statement is rechecked—not merely because the calendar changed.

Element	Recheck cadence	Trigger and method
Featured commercial and PBM documents	Monthly; full ledger quarterly	Reopen the exact primary document and record revision/effective date
Medicare formularies and federal cost rules	Quarterly and at annual-plan release	Check exact formulary ID, Evidence of Coverage, Medicare.gov, and CMS
Medicaid example	Quarterly	Reopen the named plan formulary and utilization-management key
Manufacturer offer	Monthly	Check the official offer PDF and processing terms
FDA label and generic status	Monthly	Check DailyMed label revision, FDA tracker, and Orange Book data
Cash-price publishers	Monthly	Capture the same strength and package on the same date
Provider insurance, state, and PA support	Before any provider CTA and monthly thereafter	Verify provider site and written support response
Internal links and cannibalization	Before publishing related pages	Check current sitemap and existing CombiPatch/insurance pages

What are women actually asking about CombiPatch cost?

Public comments are useful for one thing here: they show the exact confusion that sends someone searching. They do not establish national coverage, medication safety, or the right treatment. We have not verified the commenters’ plans, bills, or diagnoses, so the quotes below are voice-of-customer evidence—not medical or actuarial evidence.

“I was very surprised that it costs $135/month. I have good insurance…”

— Mayo Clinic Connect discussion

That sentence is the problem in miniature. “Good insurance” and a high member price can coexist because of a deductible, higher tier, coinsurance, or pharmacy network.

“I have insurance and due to my deductible, was just quoted $800 for 3 months of Combipatch!!!”

— r/Menopause discussion

This commenter identified the deductible. That points first to benefit math, not a formulary-denial appeal.

The practical lesson is not that these prices are typical. It is that the word covered does not answer the question what will I pay today?

Frequently asked questions about CombiPatch insurance coverage

Does Blue Cross Blue Shield cover CombiPatch?

Some BCBS plans may cover it and others may exclude it or apply restrictions. Blue Cross Blue Shield companies, state plans, employers, and pharmacy-benefit designs differ. Search the exact 2026 formulary attached to your plan, then confirm the live claim. The BCBS name alone cannot establish coverage or copay.

Does UnitedHealthcare cover CombiPatch?

Two current UHC documents list it. The commercial PDL places CombiPatch at Tier 3 with QL, while Group Medicare Advantage Formulary 00026005 lists it at Tier 3 with HRM. UHC also says its commercial PDL does not define individual benefit coverage, and certain closed two-tier benefits generally do not cover Tier 3 drugs.

Does Aetna cover CombiPatch?

Aetna’s July 2026 Standard Control and Advanced Control exclusion documents name CombiPatch as the preferred option when Climara Pro is excluded. That establishes the template preference, not universal Aetna coverage, tier, or member cost. The exact Aetna/CVS Caremark benefit still controls.

Does Express Scripts cover CombiPatch?

CombiPatch appears on Express Scripts’ current 2026 National Preferred and Basic abbreviated formulary lists. The National Preferred and National Preferred Flex exclusion lists also name it as the preferred alternative to excluded Climara Pro. Express Scripts says these lists do not guarantee coverage under every prescription plan.

Does Medicare Part D cover CombiPatch?

Some Part D and Medicare Advantage formularies list it, but Medicare has no universal formulary. Search the exact plan and formulary ID. The two Medicare documents reviewed here list it at Tier 3, and the official manufacturer offer cannot be used for prescriptions covered by or submitted to Medicare.

Does Medicaid cover CombiPatch?

It depends on the state and managed-care plan. The Denver Health Medicaid and CHP+ example lists it at Tier 2 with a $0 formulary copay, while imposing limited access, step therapy, and a quantity limit of eight patches per 28 days.

Does CombiPatch require prior authorization?

Not universally. None of the 11 entries in this ledger displays an explicit PA code for CombiPatch. Several show QL, ST, LA, or HRM instead. That does not prove your individual benefit has no review requirement; your exact formulary and live claim control.

Is there a generic CombiPatch?

No FDA-approved generic CombiPatch transdermal system appears in the current FDA Orange Book data reviewed August 3, 2026. Oral estradiol/norethindrone acetate tablets, a separate estradiol patch plus a progestogen, Climara Pro, and compounded preparations are different products or regimens.

Why is my CombiPatch copay high when it is covered?

The most likely benefit explanations are an unmet deductible, a higher brand tier, percentage coinsurance, or a non-preferred pharmacy. Ask the pharmacist whether the claim paid or rejected, then ask whether the amount is a copay, coinsurance, or deductible charge.

Can I use the savings card if insurance denies CombiPatch?

Eligible commercially insured and cash-paying U.S. patients may use the official offer subject to its terms and pharmacy processing. The offer is not valid for Medicare, Medicare Advantage, Part D, Medicaid, or other government-funded programs. “May pay as little as $25” is not a guaranteed $25 price.

Can I get a 90-day supply of CombiPatch?

The prescription and plan may allow a longer supply, but coverage and pharmacy handling must both be confirmed. CombiPatch requires refrigeration at 36°F to 46°F in its sealed pouch. Ask the dispensing pharmacy how it ships, stores, and replaces a temperature-sensitive order before using mail order.

Does CombiPatch need to be refrigerated?

Yes. The current FDA labeling directs storage in the refrigerator at 36°F to 46°F, in the sealed pouch, and says to allow the patch to reach room temperature before application.

Why is my prescription written for eight patches per 28 days?

The label directs replacement every three to four days, twice weekly, and each carton contains eight systems. Eight patches therefore correspond to a 28-day continuous-combined cycle. The Denver Health example uses that exact quantity limit.

Is an HRM flag the same as prior authorization?

No. In the UHC Group Medicare Advantage document reviewed here, HRM identifies a high-risk-medication flag for people 65 and older. CombiPatch’s entry does not also display a PA code. Read the plan’s key and ask whether any separate coverage rule applies.

Can I appeal a CombiPatch denial?

Often, but the request must match the reason. A nonformulary drug calls for a formulary exception; a high tier may call for a tiering exception; PA, ST, or QL may call for a utilization-management waiver or appeal. Commercial and Medicaid processes vary, and the denial notice states the controlling deadline.

Did FDA remove CombiPatch’s boxed warning?

No. FDA’s current updated-prescribing-information tracker lists Prometrium, Divigel, Cenestin, Enjuvia, Estring, and Bijuva. CombiPatch is not listed, and its current DailyMed label still carries the full boxed warning.

Is compounded estradiol/norethindrone a covered generic alternative?

No. A compounded preparation is not FDA-approved and is not an FDA-approved generic substitute for CombiPatch. Insurance treatment of compounded products varies. Keep the compounded and FDA-approved paths separate when comparing coverage, price, and clinical oversight.

Still not sure which HRT program is right for you?

Coverage is one variable. It is not the whole decision.

Route matters. Whether you have a uterus matters. Your symptoms, risk history, state, and whether online care is the right starting point all come before “which tier is it?”

Still not sure which HRT program is right for you? Take our free 90-second matching quiz.

Get my personalized HRT starting-point plan →

Find My HRT Path matches your situation to an appropriate starting point and flags when online care is not the right first step.

Sources

FDA and labeling

Plan and pharmacy-benefit documents

Savings, pricing, and appeals

Voice-of-customer sources

Last verified: August 2026. Formulary positions, prices, savings terms, and appeal rules change. Your current member benefit, Evidence of Coverage, denial notice, and pharmacy claim are the controlling sources.

Keep reading: